Education
About Us
Working with TipRanks
Follow Us
Robert C. II Goeltz Insider Profile
4 Followers
Robert C. II Goeltz, CFO at CytomX Therapeutics, holds 92.14K shares in Arcus Biosciences (Ticker: RCUS), holds 161.03K shares in Unity Biotechnology (Ticker: UNBX), holds 32.76K shares in CytomX Therapeutics (Ticker: CTMX).
Profitable Transactions
3 out of 3 Profitable Transactions
Average Return
+50.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Robert C. II Goeltz holds in companies
Most Profitable Insider Trade
The most profitable trade made by Robert C. II Goeltz
Robert C. II Goeltz's Trading History
CytomX Therapeutics
May 16, 2017
CFO
Uninformative Buy
110.62K
$106.78K
Unity Biotechnology
Jun 24, 2020
―
Uninformative Sell
24.01K
$9.02K
Arcus Biosciences
Oct 29, 2025
CFO
Uninformative Sell
100.00K
$1.87M
List of latest transactions for each holding click on a transaction to see Robert C. II Goeltz's performance on stock
You May Also Like
Robert C. II Goeltz insider profile FAQ
What is the percentage of profitable transactions made by Robert C. II Goeltz?
The percentage of profitable transactions made by Robert C. II Goeltz is 100%.
What is the average return per transaction made by Robert C. II Goeltz?
The average return per transaction made by Robert C. II Goeltz is 50.00%.
What stocks does Robert C. II Goeltz hold?
Robert C. II Goeltz holds: CTMX, UNBX, RCUS stocks.
What was Robert C. II Goeltz’s latest transaction?
Robert C. II Goeltz latest transaction was an Uninformative Sell of $100.00K.
What was Robert C. II Goeltz's most profitable transaction?
Robert C. II Goeltz’s most profitable transaction was an Informative Buy of RCUS stock on September 9, 2020. The return on the trade was 58.20%.
What is Robert C. II Goeltz's role in CytomX Therapeutics?
Robert C. II Goeltz's role in CytomX Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.